MiR-132 controls pancreatic beta cell proliferation and survival through Pten/Akt/Foxo3 signaling
Hassan Mziaut1, Georg Henniger2, Katharina Ganss1
1Molecular Diabetology, University Hospital and Faculty of Medicine, TU Dresden, Dresden, Germany; Paul Langerhans Institute Dresden of the Helmholtz Center Munich at the University Hospital and Faculty of Medicine of TU Dresden, Dresden, Germany; German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany.
Objective:
MicroRNAs (miRNAs) play an integral role in maintaining beta cell function and identity. Deciphering their targets and precise role, however, remains challenging. In this study, we aimed to identify miRNAs and their downstream targets involved in the regeneration of islet beta cells following partial pancreatectomy in mice.
Methods:
RNA from laser capture microdissected (LCM) islets of partially pancreatectomized and sham-operated mice were profiled with microarrays to identify putative miRNAs implicated in beta cell regeneration. Altered expression of the selected miRNAs, including miR-132, was verified by RT-PCR. Potential targets of miR-132 were selected through bioinformatic data mining. Predicted miR-132 targets were validated for their changed RNA, protein expression levels, and signaling upon miR-132 knockdown and/or overexpression in mouse MIN6 and human EndoC-βH1 insulinoma cells. The ability of miR-132 to foster beta cell proliferation in vivo was further assessed in pancreatectomized miR-132-/- and control mice.
Results:
Partial pancreatectomy significantly increased the number of BrdU+/insulin+ islet cells. Microarray profiling revealed that 14 miRNAs, including miR-132 and -141, were significantly upregulated in the LCM islets of the partially pancreatectomized mice compared to the LCM islets of the control mice. In the same comparison, miR-760 was the only downregulated miRNA. The changed expression of these miRNAs in the islets of the partially pancreatectomized mice was confirmed by RT-PCR only in the case of miR-132 and -141. Based on previous knowledge of its function, we focused our attention on miR-132. Downregulation of miR-132 reduced the proliferation of MIN6 cells while enhancing the levels of pro-apoptotic cleaved caspase-9. The opposite was observed in miR-132 overexpressing MIN6 cells. Microarray profiling, RT-PCR, and immunoblotting of the latter cells demonstrated their downregulated expression of Pten with concomitant increased levels of pro-proliferative factors phospho-Akt and phospho-Creb and inactivation of pro-apoptotic Foxo3a via its phosphorylation. Downregulation of Pten was further confirmed in the LCM islets of pancreatectomized mice compared to the sham-operated mice. Moreover, overexpression of miR-132 correlated with increased proliferation of EndoC-βH1 cells. The regeneration of beta cells following partial pancreatectomy was lower in the miR-132/212-/- mice than the control littermates.
Conclusions:
This study provides compelling evidence about the critical role of miR-132 for the regeneration of mouse islet beta cells through the downregulation of its target Pten. Hence, the miR-132/Pten/Akt/Foxo3 signaling pathway may represent a suitable target to enhance beta cell mass.
Insights
MicroRNA-132 (miR-132) is crucial for regenerating mouse islet beta cells by downregulating Pten. Targeting the miR-132/Pten/Akt/Foxo3 pathway could enhance beta cell mass.
Area of Science:
- Endocrinology
- Molecular Biology
- Regenerative Medicine
Background:
- MicroRNAs (miRNAs) are vital regulators of beta cell function and identity.
- Understanding miRNA roles and targets is key for beta cell research.
- Islet beta cell regeneration mechanisms are not fully elucidated.
Purpose of the Study:
- To identify miRNAs and their targets involved in islet beta cell regeneration after partial pancreatectomy in mice.
- To investigate the specific role of miR-132 in beta cell proliferation and survival.
- To explore the therapeutic potential of targeting the miR-132 pathway for enhancing beta cell mass.
Main Methods:
- Profiling of miRNA expression in islets using microarrays and RT-PCR after partial pancreatectomy.
- Bioinformatic analysis to predict and validate miR-132 targets.
- In vitro studies using MIN6 and EndoC-βH1 cells to assess the effects of miR-132 modulation on cell proliferation and apoptosis.
- In vivo studies using miR-132 knockout mice to evaluate beta cell regeneration capacity.
Main Results:
- Partial pancreatectomy induced beta cell proliferation and upregulated miR-132 and miR-141 expression in mouse islets.
- miR-132 downregulation reduced beta cell proliferation and increased apoptosis, while overexpression promoted proliferation.
- miR-132 targets Pten, leading to increased Akt and Creb phosphorylation and Foxo3a inactivation.
- Beta cell regeneration was impaired in miR-132 knockout mice following pancreatectomy.
Conclusions:
- miR-132 plays a critical role in mouse islet beta cell regeneration by downregulating Pten.
- The miR-132/Pten/Akt/Foxo3 signaling pathway is a key regulator of beta cell mass.
- This pathway represents a potential therapeutic target for increasing beta cell mass.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cell Specific Gene Expression
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...


